Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Nucleolus02:55

The Nucleolus

8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.

Breast cancer (Dove Medical Press)·2026
Same author

Global characterization of extrachromosomal circular DNA in cerebrospinal fluid of lung adenocarcinoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Risk factors for cancer among the working population in China: a cross-sectional analysis of baseline data from the WECAN project.

BMJ open·2025
Same author

Gliomas Analysis via Multimodal MRI-Deep Learning Fusion: Technical Innovations in Segmentation, Molecular Subtyping, and Clinical Translation Pathways.

Advances in medical education and practice·2025
Same author

Characterization of the genomic landscape in liver oligometastatic NSCLC.

BMC cancer·2025
Same author

Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis.

Radiation oncology (London, England)·2025

Related Experiment Video

Updated: Aug 11, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Genomic features and its potential implication in bone oligometastatic NSCLC.

Rongxin Liao1, Guangming Yi1, Lu Shen2

  • 1Department of Cancer Center, Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China.

BMC Pulmonary Medicine
|February 9, 2023
PubMed
Summary

This study reveals that bone oligometastatic non-small cell lung cancer (NSCLC) has targetable genomic alterations. These findings support personalized treatment strategies for advanced NSCLC patients with bone metastases.

Keywords:
Bone oligometastasisGenomic profilingNSCLCNext-generation sequencingTumor mutational burden

More Related Videos

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Related Experiment Videos

Last Updated: Aug 11, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Area of Science:

  • Oncology
  • Genomics
  • Precision Medicine

Background:

  • Oligometastatic non-small cell lung cancer (NSCLC) may benefit from local therapy.
  • Bone oligometastasis is frequent in advanced lung cancer, but its molecular characteristics are poorly understood.

Purpose of the Study:

  • To investigate the genomic landscape of bone oligometastatic NSCLC.
  • To identify actionable targets for precision medicine in this patient population.

Main Methods:

  • Comprehensive genomic analysis using next-generation sequencing.
  • Analysis of paired blood and tissue samples from 31 bone oligometastatic NSCLC patients.

Main Results:

  • Identified 186 mutations across 105 cancer-relevant genes, with EGFR and TP53 being the most frequent.
  • Detected targetable alterations in 74.19% of patients, with 16.13% having multiple actionable mutations.
  • Characterized mutational processes including smoking, aging, homologous recombination deficiency, and APOBEC signatures.

Conclusions:

  • The study comprehensively elucidates the genomic features of bone oligometastatic NSCLC.
  • Findings may optimize individualized cancer treatment strategies in the era of precision medicine.